Provided by Tiger Trade Technology Pte. Ltd.

Evogene

0.5120
+0.01202.40%
Post-market: 0.4979-0.0141-2.75%19:54 EDT
Volume:2.31M
Turnover:1.16M
Market Cap:6.20M
PE:-0.37
High:0.5306
Open:0.5000
Low:0.4749
Close:0.5000
52wk High:1.50
52wk Low:0.3700
Shares:12.10M
Float Shares:12.02M
Volume Ratio:0.34
T/O Rate:19.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3669
EPS(LYR):-1.0776
ROE:-171.75%
ROA:-32.89%
PB:-2.44
PE(LYR):-0.48

Loading ...

Evogene, BCDD announces strategic joint initiative

TIPRANKS
·
Jul 08

Evogene Partners with Tel Aviv University Drug Discovery Center on Ai-driven Small-molecule R&D

Reuters
·
Jul 08

Evogene achieves integration of agentic systems with ChemPass AI platform

TIPRANKS
·
Jun 24

Evogene, Google Cloud Integrate Agentic AI into Chempass Platform in Expanded Collaboration

Reuters
·
Jun 24

Evogene Sets Up $2.9 Million At-the-Market Share Offering With A.G.P.

TIPRANKS
·
Jun 12

Evogene enters ATM equity sales agreement for up to $2.93 million offering

Reuters
·
Jun 12

Evogene to present pharma division achievements at BIO International Convention

Reuters
·
Jun 09

Evogene Announces Successful Completion Of Phase 1 Clinical Study Of Bmc128, A Rationally Designed Live Bacterial Product, In Combination With Nivolumab By Its Subsidiary Biomica

Reuters
·
Jun 02

Evogene completes Phase 1 trial of Biomica’s BMC128 plus Bristol-Myers’ Opdivo in advanced solid tumors

Reuters
·
Jun 02

Analysts Are Bullish on These Healthcare Stocks: Evogene (EVGN), NanoViricides (NNVC)

TIPRANKS
·
May 27

Evogene price target lowered to $2.15 from $2.25 at Alliance Global

TIPRANKS
·
May 27

Evogene Earnings Call: AI Momentum vs. Cash Strain

TIPRANKS
·
May 21

Evogene Ltd reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 20

Evogene Tightens Focus on AI Small-Molecule Platform as Q1 2026 Revenue Falls

TIPRANKS
·
May 20

Evogene reporta Q1 cont. ops. EPS (60c) vs. (26c) last year

TIPRANKS
·
May 20

Evogene Q1 FY26 net loss widens to USD 5.9 million; revenue drops 87.22% to USD 334,000

Reuters
·
May 20

Evogene Q1 EPS $(0.60) Misses $(0.27) Estimate, Sales $334.000K Miss $350.000K Estimate

Benzinga
·
May 20

Press Release: Evogene Reports First Quarter 2026 Financial Results

Dow Jones
·
May 20

Evogene’s Ag Plenus, Bayer End Herbicide Collaboration as APTH1 Target Falls Short

TIPRANKS
·
May 19

Evogene unit AgPlenus, Bayer discontinue herbicide development project

Reuters
·
May 19